New England Research & Management, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1596077 CHICAGO, IL

Position in REGN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,166,801

+$1,722,533 QoQ

Shares Held

3,475

+504.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.85%

of 13F equity value

Holder Rank

#504

of 1,322 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New England Research & Management, Inc. holds $4,649,048 across 5 Biotechnology names. REGN ranks #1 (46.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	3,475	$2,166,801
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,575	$1,279,079
3	MRNA	Moderna, Inc.	6,850	$479,705
4	INCY	Incyte Corp	3,575	$405,262
5	AXSM	Axsome Therapeutics, Inc.	1,300	$318,201

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,166,801	3,475	+504.3%	Shares	Sole	2026-07-09
2026-03-31	$444,268	575	+15.0%	Shares	Sole	2026-05-07
2025-12-31	$385,935	500	-17.4%	Shares	Sole	2026-01-07
2025-06-30	$317,625	605	0.0%	Shares	Sole	2025-07-09
2025-03-31	$383,709	605	-35.6%	Shares	Sole	2025-04-16
2023-06-30	$675,427	940	+0.9%	Shares	Sole	2023-07-05
2022-09-30	$642,026	932	-6.0%	Shares	Sole	2022-10-06
2022-06-30	$585,809	991	+4.8%	Shares	Sole	2022-07-20
2022-03-31	$660,705	946	-3.0%	Shares	Sole	2022-04-20
2021-12-31	$615,732	975	+58.5%	Shares	Sole	2022-01-05
2021-09-30	$372,185	615	-63.0%	Shares	Sole	2021-10-08
2021-06-30	$927,176	1,660	-10.8%	Shares	Sole	2021-07-15
2021-03-31	$880,040	1,860	+63.9%	Shares	Sole	2021-04-16
2020-12-31	$548,329	1,135	-29.3%	Shares	Sole	2021-01-07
2020-09-30	$898,446	1,605	—	Shares	Sole	2020-10-08
No filing history on record for this holder in this stock.